Next Generation Personalized Neuroblastoma Therapy
Clinical trial NCT02780128 · TERMINATED
Trial details
- NCT number
- NCT02780128
- Sponsor
- Yael P Mosse
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2022-08-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.